| abstract |
formulation for the combined use of [10] -gingerol (10g) with doxorubicin (doxo) for the treatment of triple negative breast cancer (cmtn). new formulation for the combined use of [10] -gingerol (10g) with doxorubicin (doxo) for the treatment of triple negative breast cancer (cmtn), which has lesser side effects, being more effective and effective in inhibiting the size of tumors primary CMTNs, as well as pulmonary and bone metastases and with reduced toxic effects of standard chemotherapy, which is obtained from natural products that are rich sources of molecules with antitumor and antimetastatic activities, containing gingerois molecules, present in ginger, which present greater cytotoxic activity in cmtn. |